NL-OMON38092
Completed
Not Applicable
Improved diagnosis of clinically occult breast lesions - IDO
niversitair Medisch Centrum Utrecht0 sites128 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- breast neoplasms
- Sponsor
- niversitair Medisch Centrum Utrecht
- Enrollment
- 128
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Female gender;
- •\- Age \>\= 18 years;
- •\- Nonpalpable mammographically suspicious breast lesion (classified as BIRADS 3\-5\) requiring stereotactic biopsy.
Exclusion Criteria
- •\- Legal incapability;
- •\- Insufficient command of the Dutch language;
- •\- Contraindication for temporarily stopping anticoagulant therapy;
- •\- Inability to maintain a prone position for 1 hour;
- •\- Ipsilateral breast implant;
- •\- Lactation;
- •\- Implanted electronic device;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Detectability of breast lesions of dense breast using low-dose computed tomographyBreast lesionsJPRN-UMIN000029145Hokkaido University80
Active, not recruiting
Not Applicable
ocalization of the sentinel node with microbubble contrast and Iodine-markersPatient with breast cancer with an indication for sentinel lymph node biopsyTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2012-000333-40-NLniversity Medical Center Utrecht120
Completed
Not Applicable
Towards plannable breast surgery: diagnostic accuracy of microbubble enhanced Iodine-125 seed localization of the sentinel lymph node (MIB study)breast cancerbreast carcinoma1000629110006295NL-OMON37670niversitair Medisch Centrum Utrecht120
Active, not recruiting
Phase 1
Multihance versus Dotarem at 3 Teslathe aim of this study is to intraindividually compare the use of equivalent doses of gadobenate dimeglumine (MultiHance, Bracco Imaging, Milan, Italy) and gadoterate meglumine (DOTAREM, Guerbet, France) for breast MR imaging by using a prospective study design, evaluated independently by blinded readers.Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]EUCTR2011-005498-21-ATMed. Univ. Wien, Univ. Klinik für Radiodiagnostik130
Not yet recruiting
Not Applicable
Biomarker detection for benign breast diseases and primary breast cancer by serum and tissue protein profiling.benign breast diseasesbreast cancer10006291NL-OMON30316Slotervaartziekenhuis380